{"url_path":"/sec/ptix/8-k/2026-02-24/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-24","source_url":"https://www.sec.gov/Archives/edgar/data/1022899/0001493152-26-007800-index.html","accession_number":"0001493152-26-007800","cik":"0001022899","ticker":"PTIX","issuer_name":"Protagenic Therapeutics, Inc.\\new","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022899/0001493152-26-007800-index.html","primary_entity_key":"0001022899","primary_entity_name":"Protagenic Therapeutics, Inc.\\new"},"word_count":38,"has_tables":true,"body_markdown":"**Item\n3.02 Unregistered Sales of Equity Securities**\n\n \n\nThe\nreturn and cancellation of shares of PTIX common stock issued pursuant to the SEA were effected pursuant to the Unwind Agreement and\ndid not involve the issuance of new securities."}